STAT3 Inhibitor (Vividion Therapeutics/Bayer)

N/A

Report date: 2025/01/26 18:06:58
NME

Base Information

Drug NameSTAT3 Inhibitor (Vividion Therapeutics/Bayer)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsImmune System DiseasesPsoriasisInflammatory Bowel Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVividion Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVividion Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsImmune System DiseasesPsoriasisInflammatory Bowel Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A